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and 1970s the nurse practitioner became a new professional in the USA 
by reason of shortage of primary care physicians. Van Offenbeek et al 
(2003) described the effects of the embedding of the nurse practitioner 
in the health system in the Netherlands. The main part of the role of 
the nurse practitioner was the coordination of patient care, performing 
medical acts, consultation and keeping medical consulting hours. In ad-
dition, the role of the nurse practitioner seemed particularly suitable to 
integrate the nursing and medical and social aspects of patient care.
Only in 1997, the ﬁrst nurse practitioner education in the Netherlands 
was established, and in 2001 the Netherlands Cancer Institute-Antoni 
van Leeuwenhoek Hospital appointed its ﬁrst nurse practitioner. The 
nurse practitioner thorax oncology started in February 2004. 
The nurse practitioner is a member of the thoracic oncology group, 
consisting of dedicated (radiation) oncologists and surgeons. He 
integrates different roles; nursing care, expert, consultant, education, 
research and nursing leadership. This focusses on particular prob-
lems seem in lung cancer and mesothelioma patients. He forms a link 
between outpatient clinic and clinical care, performing all medical 
actions that are written in dedicated protocols and consulting medical 
specialists for situations that go beyond the protocols. He prescribes 
medication under supervision of medical specialists. He is especially 
equiped to integrate complex medical-social problems and counseling 
for patients and their families. In the clinic, he educates and supports 
the nursing staff conserning speciﬁc lung cancer related issues, like 
nebulization and pleural ﬂuid drainage. He is actively involved in 
medical research, e.g. setting-up the study logistics, informing and sup-
porting patients in the study. 
Conclusion: The nurse practitioner is a fairly new profession in the 
Netherlands Cancer Institute. This profession creates a good balance 
between nursing care and medical care. From the patient’s point of 
view it is important that the integrated care is given by one profession-
al. He is allowed to prescribing medication, although political debate 
on this problem is still ongoing.
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Background: Management of patients with lung cancer requires the 
involvement of multiple specialists. A multidisciplinary approach to 
care is advocated to facilitate shared-decision making which can im-
prove the quality of care. Setting up multidisciplinary clinics is difﬁcult 
because of the number of different specialists needed and their widely 
disparate work schedules. A multidisciplinary thoracic oncology con-
ference (MD-TOC) involving the key specialists is potentially a way of 
achieving the beneﬁts of multidisciplinary care. However, the effective-
ness of this approach depends on compliance with recommendations. 
We report our experience with patients presented to a new MD-TOC at 
the Methodist University Hospital, Memphis TN, a tertiary healthcare 
teaching facility in the USA. The period of analysis spans the time from 
inauguration of the conference in February 2006 to January 2007. 
Methods: Descriptive retrospective comparison of MD-TOC recom-
mendations and actual clinical management of consecutive patients. 
MD-TOC participants included a thoracic surgeon, pulmonologist, 
medical oncologist, radiation oncologist, pathologist and radiolo-
gist. Actual clinical management information was obtained from an 
electronic medical record system at the University of Tennessee Cancer 
Institute. MD-TOC recommendations were obtained from meeting 
logs. This study was approved by the Institutional Review Board of the 
University of Tennessee.
Results: Fifty two patients were presented, 28 females and 24 males, 
median age was 63 years (range 43 to 77). The patients were repre-
sentative of an urban population in the southern US, with 35 African 
American, 14 caucasian, 2 hispanic and 1 native American. Employ-
ment status was as follows: 6 employed, 13 unemployed, 16 retired, 
3 disabled, 13 unknown, 1 prison inmate. The health care payor 
characteristics were as follows: 21 with commercial insurance, 6 with 
medicare 6; 3 with medicaid 3; 20 with no insurance, 1 unknown and 1 
‘other’.
Nine of 52 patients had no diagnosed cancer: 2 expired before biopsy, 2 
had benign lung lesions, 3 refused biopsy and 2 were lost to followup. 
Forty-three patients (82.7%) were diagnosed with cancer with the fol-
lowing histology: adenocarcinoma 21 (49%), squamous cell 16 (37%), 
small cell 4 (9%), large cell neuroendocrine 1 (2%), bronchoalveolar 
cell carcinoma 1 (2%). Five of 43 patients (11.6%) were not clinically 
staged: 3 declined evaluation, 1 failed to followup, 1 patient was treated 
with chemotherapy without documented staging. Thirty-eight patients 
were clinically staged as follows: stage I, 6 (15.8%); II, 1 (2.6%); IIIA, 
6 (15.8%); IIIB, 12 (31.6%); IV, 13 (34.2%).
MDTOC recommendations and clinical concordance were as follows: 
18 patients were recommended for an invasive procedure, which was 
performed in 9 (50%). Nine of 18 patients (2 for surgical resection, 4 
for staging percutaneous CT-guided biopsy, 3 for staging mediastinos-
copy) did not undergo the recommended surgical procedure. Three of 
these nine patients declined the recommended procedure and received 
no treatment, 6 of 9 patients were treated with chemotherapy and/or 
radiation therapy without the recommended procedure. Of the 31 
patients for whom chemotherapy was recommended, 30 received treat-
ment, 1 patient declined and was lost to followup. Radiation therapy 
was recommended for 16 patients, all of whom received that modality 
of treatment. Participation in a clinical trial was recommended for 5 
patients, none participated.
Conclusions: There is a high level of concordance with non-surgical 
treatment recommendations of an MD-TOC, but relatively poor con-
cordance with recommendations for invasive staging procedures and 
surgical management. The reasons for this include patient and provider 
dissent. The multi-disciplinary thoracic oncology clinic environment, 
with active patient participation, may be a better model to ensure bet-
ter concordance with evidence-based recommendations and clinical 
practice.
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Background: The objective of this study was to identify which symp-
toms commonly associated with advanced non-small-cell lung cancer 
(NSCLC) are most likely to change (worsen or improve) in association 
